Disease Area Leader Ophthalmology

at  Roche

Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.
The Position
Roche - we advance science so that we all have more time with the people we love
Our Pharma Global Product Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference.
The Disease Area Leader - Ophthalmology role is critical to deliver on our Pharma Ambition. As the therapeutic area Late-Stage conduit into our early development teams, the Disease Area Leader plays a unique role in providing strategic insights and commercialization perspective to shape and steward our portfolio and create clarity on path to value, in particular through contribution to Asset and Disease Area Strategies and Business Development assessments.

• Asset Team member for Research and Early Development (REDs): Partner with R&Ds units and cross-functionally to ensure organizational alignment around understanding of future disease area context and ensure pipeline Asset strategies and Disease Strategies reflect value to patients, society and Roche. This includes providing global strategic guidance and business inputs into the development of Target Product Profiles, Clinical Development Plans with strong emphasis on value demonstration for pipeline molecules (until PivGo or LCL assigned)
• Disease Area Strategy: lead a cross-functional end-to-end team in the development and maintenance of disease area strategies that reflects near and long term pipeline portfolio evolution to deliver value to patients, society and Roche.
• Partnering GPS TA SPOC: Represent GPS in assessment of external landscape and partnering opportunities in the context of Disease Area Strategies and provide specific asset and platform/technology business input, path to value assessments and strategic guidance to support due diligence.
• Cross-Functional Team Leadership: In partnership with CLT, lead the integrated development and commercialization planning (IDCP) process to bring affiliate inputs into asset and disease area strategies and decision making.
• Collaboration across E2E value chain with REDs, partnering, PD and affiliates